HALEOS LABS
Sector : Pharmaceuticals and health care | Smallcap | BSE
Here's the live share price of Haleos Labs along with daily highs, lows, percentage changes and volume trends, and, all financial information.
1.23₹ 16.20
As on Jan 16, 2026, 4:01 PM IST
Haleos Labs Price Performance
Today's LowToday's High
₹1,335.00₹1,340.00
₹1,335.00
52 Weeks' Low52 Weeks' High
₹956.05₹1,680.00
₹1,335.00
Open Price
₹1,340.00
Prev. Close
₹1,318.80
Volume
9
Over the last 5 years, the share price of Haleos Labs has gained 17.94% CAGR. Over the past year, the corresponding return has been 3.89%.
Haleos Labs’s current P/E of 21.59x helps give context to how the market is valuing the stock based on recent earnings and growth expectations.
Haleos Labs Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Haleos Labs | 5.37 | -1.04 | 20.81 | 0.75 | 3.89 | 28.26 | 17.94 |
| Sun Pharmaceutical Industries | -3.26 | -6.77 | -0.33 | -1.74 | -6.30 | 17.47 | 23.55 |
| Divi's Laboratories | -7.24 | -2.48 | -7.27 | -9.54 | 3.79 | 22.41 | 11.48 |
| Torrent Pharmaceuticals | 3.23 | 8.54 | 14.30 | 16.73 | 28.72 | 37.16 | 25.42 |
| Cipla | -5.47 | -7.41 | -12.16 | -6.51 | -3.91 | 9.04 | 11.58 |
| Lupin | -0.16 | 3.07 | 12.33 | 11.39 | 3.13 | 42.48 | 15.42 |
| Dr. Reddy's Laboratories | -3.56 | -8.30 | -7.13 | -7.66 | -10.95 | 10.25 | 2.91 |
| Zydus Lifesciences | -1.78 | -4.28 | -10.97 | -10.49 | -11.58 | 26.81 | 13.20 |
| Mankind Pharma | -3.72 | 0.36 | -14.54 | -19.80 | -18.55 | 14.14 | 8.26 |
| Alkem Laboratories | -1.30 | 1.73 | 2.56 | 14.18 | 9.02 | 23.64 | 13.45 |
| Aurobindo Pharma | -2.61 | -2.17 | 5.97 | 1.15 | -0.90 | 38.16 | 4.96 |
| Biocon | -1.19 | -2.91 | 5.36 | -5.47 | -4.47 | 14.59 | -3.54 |
| Abbott India | -1.40 | -0.04 | -7.24 | -18.98 | -1.08 | 8.45 | 13.38 |
| Laurus Labs | -1.70 | 5.42 | 18.24 | 29.50 | 87.29 | 44.52 | 24.48 |
| Glenmark Pharmaceuticals | -0.94 | 2.08 | 6.82 | -10.71 | 35.39 | 68.38 | 32.01 |
| GlaxoSmithKline Pharmaceuticals | -2.08 | -9.94 | -15.18 | -26.66 | 12.74 | 21.25 | 8.74 |
| Ipca Laboratories | -5.19 | 6.55 | 15.69 | 0.95 | -3.60 | 20.45 | 6.91 |
| Anthem Biosciences | -0.91 | -6.13 | -17.66 | -14.62 | -14.62 | -5.13 | -3.11 |
| Ajanta Pharma | -3.67 | 2.57 | 9.33 | -4.41 | -6.79 | 31.71 | 18.09 |
| J B Chemicals & Pharmaceuticals | 1.47 | 6.79 | 13.15 | 15.12 | 9.63 | 24.59 | 30.32 |
Over the last one year, Haleos Labs has gained 3.89% compared to peers like Sun Pharmaceutical Industries (-6.30%), Divi's Laboratories (3.79%), Torrent Pharmaceuticals (28.72%). From a 5 year perspective, Haleos Labs has outperformed peers relative to Sun Pharmaceutical Industries (23.55%) and Divi's Laboratories (11.48%).
Haleos Labs Financials
Haleos Labs Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 1,293.04 | 1,312.5 |
| 10 | 1,306.15 | 1,309.76 |
| 20 | 1,316.53 | 1,313.02 |
| 50 | 1,305.45 | 1,294.68 |
| 100 | 1,224.27 | 1,261.76 |
| 200 | 1,228.38 | 1,226.94 |
Haleos Labs Share Holding Pattern
In the latest quarter, Haleos Labs saw a rise in promoter holding to 71.78%, while DII stake increased to 0.29%, FII holding unchanged at 0.00%, and public shareholding moved down to 27.91% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Haleos Labs Corporate Actions
Date Time | Announcement |
|---|---|
| Jan 13, 2026, 10:16 PM IST | Haleos Labs - Report (Special Window) |
| Jan 07, 2026, 10:43 PM IST | Haleos Labs - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 |
| Dec 08, 2025, 11:22 PM IST | Haleos Labs - Report (Special Window) |
| Dec 07, 2025, 12:27 AM IST | Haleos Labs - Demand Notice |
| Nov 25, 2025, 11:52 PM IST | Haleos Labs - New Logo |
About Haleos Labs
Haleos Labs Ltd. is a Public Limited Listed company incorporated on 31/05/2006 and has its registered office in the State of Telangana, India. Company's Corporate Identification Number(CIN) is L74930TG2006PLC050223 and registration number is 050223. Currently Company is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company's Total Operating Revenue is Rs. 333.37 Cr. and Equity Capital is Rs. 3.02 Cr. for the Year ended 31/03/2025.
- IndustryPharmaceuticals
- AddressPlot No.19-III, Road No.71, Hyderabad Telangana 500096
- Contact
Management
- Mr. TVVSN MurthyManaging Director
- Mr. T V PraveenExecutive Director
- Mrs. Sudeepthi GopineediWhole Time Director
- Mr. P Sarath KumarIndependent Director
- Dr. Srinivas SamavedamIndependent Director
- Dr. Mannam MalakondaiahIndependent Director
- Mrs. Sundaramma PatibandlaIndependent Woman Director
FAQs on Haleos Labs Share Price
What is the share price of Haleos Labs?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Haleos Labs is ₹1,335.00 as on Jan 16, 2026.
What kind of stock is Haleos Labs?
The Haleos Labs is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
What is the Market Cap of Haleos Labs?
The market cap of Haleos Labs is ₹403.61 Cr as on Jan 16, 2026.
What are today's High and Low prices of Haleos Labs?
Today’s highest and lowest price of Haleos Labs are ₹1,340.00 and ₹1,335.00.
What are the 52 Week High and 52 Week Low of Haleos Labs?
The 52-week high/low is the highest and lowest price at which Haleos Labs stock has traded in the past 52-week or nearly a year. The 52-week high of Haleos Labs is ₹1,680.00 and 52-week low of Haleos Labs is ₹956.05 as on Jan 16, 2026.
How has the Haleos Labs performed historically in terms of returns?
The Haleos Labs has shown returns of 1.23% over the past day, -1.04% for the past month, 20.81% over 3 months, 3.89% over 1 year, 28.26% across 3 years, and 17.94% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Haleos Labs?
P/E ratio of and PB ratio of Haleos Labs are 21.59 and 1.96 on Jan 16, 2026. While the company gives a dividend yield of 0.11 per annum.
✕
Market Pulse